General
Clinical trial halts as two patients die from cerebral edema, FDA to answer questions
 

Clinical trial halts as two patients die from cerebral edema, FDA to answer questions

Shared by:

 
Two deaths have halted a clinical trial that explores a new way to treat cancer. The FDA is expected to face added pressure for allowing the trial to continue just days after it was first halted.
 
today.mims.com
 
28 Nov 2016 - General
 
This sounds very controversial because there is an issue on transparency on allowing clinical trials to resume. I hope that in the next few days, the US FDA can provide a detailed account on how they conduct their reviews, from which they base their judgment whether to allow a clinical trial to progress or not. I have never encountered neurotoxic effects from Fludarabine so I conducted literature research. Apparently, there have been few case reports of severe neurotoxicity that is associated wi...
 (Total 123 words)
Ohh, very sad to listen the death of two patients who have halted a new clinical trial that explores a new approach for the treatment of cancer. The reason for deaths during company’s experimental therapy was brain swelling and it was the second fatal incident by the same company during Experimentation.The Company has been working on treatments made by harvesting a patient's own immune cells and rewiring them to home in on tumors in the body. These therapies known as CAR-Ts had promising ear...
 (Total 113 words)